Germany animal vaccine market is estimated to grow at a CAGR of around 6.0% during the forecast period. Germany is one of the potential countries lying on the bay and is covered by rivers, lakes, ponds and other water bodies. Fisheries and aquaculture are an important source of food and is being significantly preferred by the residents of the country. Therefore, there is a considerable size of the aquaculture industry in the country, which contributes significantly to the growth of the market. There is a significant rise in the demand for seafood, including crocodile, fishes, and pawns, which increases the need for fish and aqua vaccines in the country. Enteric Redmouth (ERM) vaccine, Vibrio anguillarum vaccine, Furunculosis vaccine, Vibrio salmonicida vaccine, Combined Vibriosis/Furunculosis vaccine, IPN Virus vaccine, Pasteurella vaccine, Combined Pasteurella/Vibriosis vaccine, Vibriosis vaccine for cod, Shrimp Vibriosis vaccine and others are some of the fish vaccines being used in fisheries and aquaculture.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/germany-animal-vaccine-market
Key players in the Germany animal vaccine market include Zoetis, Inc., Elanco, Merck & Co., Inc., and Ceva Santé Animale. These players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations to maintain their competitiveness and increase their market share. For instance, in May 2019, Ceva Santé Animale and IDT Biologika GmbH have entered into an agreement for Ceva to acquire veterinary biopharmaceutical portfolio and R&D activities of IDT. This will enable IDT to focus on the production of pharmaceuticals and human biotechnology vaccines for national and global markets. Ceva is planning to invest significantly to develop a new Global Swine Innovation Centre at IDT Research in Riems, Germany and IDT’s existing Dessau site. This center is expected to reinforce the biological R&D capabilities of Ceva and will combine the expertise of both the company’s research teams and advanced pipelines. As a result, this acquisition will offer strong growth potential for Ceva.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/germany-animal-vaccine-market
Market Segmentation
By Type
- Porcine Vaccines
- Poultry Vaccines
- Livestock Vaccines
- Aquaculture Vaccines
- Companion Animal Vaccines
- Other Animal Vaccines
By Technology
- Live Attenuated Vaccine
- Killed/Inactive Vaccine
- Recombinant Vaccine
- Vectored Vaccine
- Subunit Vaccine
- DNA Vaccine
- Chimeric Vaccine
- Others
Company Profiles
- AniCon Labor GmbH
- Ceva Santé Animale
- Elanco
- Heska Corp.
- Merck & Co., Inc.
- Neogen Corp.
- VEROVACCiNES GmbH
- Vetoquinol S.A.
- Virbac SA
- Zoetis, Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
